4.8 Article

How to improve care in outpatients with cirrhosis and ascites: A new model of care coordination by consultant hepatologists

Journal

JOURNAL OF HEPATOLOGY
Volume 59, Issue 2, Pages 257-264

Publisher

ELSEVIER
DOI: 10.1016/j.jhep.2013.03.010

Keywords

Day hospital; Care management program; Health care costs; Health care system; Hospital readmission; Mortality; Quality of assistance

Ask authors/readers for more resources

Background & Aims: The development of ascites in patients with cirrhosis is associated with a high rate of health care utilization. New models of specialized caregiving support are necessary to optimize its management. The aim of the study was to evaluate the efficacy and financial sustainability of the Care management check-up as a new model of specialized caregiving support based on a series of diagnostic facilities performed in real time and on the integrated activity of consultant hepatologists at the hospital unit for outpatients, dedicated nurses, physicians in training and primary physicians, compared to standard care in outpatients with cirrhosis and ascites. Methods: 100 cirrhotic patients admitted to our hospital were allocated, after discharge, to the Care management check-up group (group 1), or to the Standard outpatient care group (group 2), and followed prospectively as outpatients up to death or for at least 12 months. Patients of the two groups could also access to a Day hospital when an invasive procedure was required. In group 1, the Care management check-up and the Day hospital taken together defined the Care management program. Results: Twelve-month mortality was higher in group 2 than in group 1 (45.7% vs. 23.1%, p <0.025). The rate of 30-day readmission was also higher in group 2 (42.4% vs. 15.4%, p <0.01). The global cost attributable to the management per patient-month of life was lower (1479.19 +/- 2184.43 (sic)) in group 1 than (2816.13 +/- 3893.03 (sic)) in group 2 (p <0.05). Conclusions: The study suggests that this new model of specialized caregiving reduces 12-month mortality in patients with cirrhosis and ascites as well as the global health care costs for their management. (C) 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available